Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Medtronic recalls surgical devices | FDA approves new cholesterol pill | Stereotaxis completes major acquisition | AI & TAVR
Friday, July 17, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Medtronic recalls surgical devices due to risk of blood contamination

Trace amounts of blood were identified within the sealed packaging of these devices. No patients were exposed to the foreign material, and no adverse events were reported, but Medtronic is recalling the devices as a precaution.

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

Medtronic recalls surgical devices due to risk of blood contamination

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Trace amounts of blood were identified within the sealed packaging of these devices. No patients were exposed to the foreign material, and no adverse events were reported, but Medtronic is recalling the devices as a precaution.
READ MORE >

FDA approves first cholesterol pill of its kind

Enlicitide, the new oral PCSK9 inhibitor from Merck, will be sold under the brand name Lipfendra. It is approved to reduce LDL-C in patients with hypercholesterolemia, including HeFH.

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first cholesterol pill of its kind

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Enlicitide, the new oral PCSK9 inhibitor from Merck, will be sold under the brand name Lipfendra. It is approved to reduce LDL-C in patients with hypercholesterolemia, including HeFH.
READ MORE >

Stereotaxis completes major cardiology tech acquisition

The deal, first announced in April, includes an upfront payment of $20 million and up to an additional $25 million based on certain milestones.

READ MORE >
Handshake
Share on Twitter Share on Facebook Share on Linkedin

Stereotaxis completes major cardiology tech acquisition

Share on Twitter Share on Facebook Share on Linkedin
Handshake
The deal, first announced in April, includes an upfront payment of $20 million and up to an additional $25 million based on certain milestones.
READ MORE >

How AI can help heart teams identify TAVR patients

Many heart patients who would benefit from TAVR are still missing out on the care they need. AI, it turns out, can help cardiologists find those patients. An upcoming webinar is set to explore this topic at length.

READ MORE >
AI healthcare doctor surgery procedure artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

How AI can help heart teams identify TAVR patients

Share on Twitter Share on Facebook Share on Linkedin
AI healthcare doctor surgery procedure artificial intelligence
Many heart patients who would benefit from TAVR are still missing out on the care they need. AI, it turns out, can help cardiologists find those patients. An upcoming webinar is set to explore this topic at length.
READ MORE >

Featured Articles

CMS proposes Medicare payment cuts in 2027—physician groups pledge to bring about change

Cardiologists received a nice bump in pay in 2026 thanks to a one-time 2.5% conversion factor increase. That expires at the end of the year, however, and physicians will see their payments decrease as a result.

READ MORE >
Medicare money bills dollars
Share on Twitter Share on Facebook Share on Linkedin

CMS proposes Medicare payment cuts in 2027—physician groups pledge to bring about change

Share on Twitter Share on Facebook Share on Linkedin
Medicare money bills dollars
Cardiologists received a nice bump in pay in 2026 thanks to a one-time 2.5% conversion factor increase. That expires at the end of the year, however, and physicians will see their payments decrease as a result.
READ MORE >

The crisis continues: Nearly 90% of deaths from ischemic heart disease could have been prevented

There has been progress over the years, researchers noted, but there is still a lot of work to do. 

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

The crisis continues: Nearly 90% of deaths from ischemic heart disease could have been prevented

Share on Twitter Share on Facebook Share on Linkedin
women doctors
There has been progress over the years, researchers noted, but there is still a lot of work to do. 
READ MORE >

In Case You Missed It

Chest pain drug lowers risk of kidney injury after PCI

Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.

READ MORE >
pills-384846_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Chest pain drug lowers risk of kidney injury after PCI

Share on Twitter Share on Facebook Share on Linkedin
pills-384846_960_720.jpg
Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.
READ MORE >

Investigational heart drug for nonobstructive HCM one step closer to FDA approval

No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Investigational heart drug for nonobstructive HCM one step closer to FDA approval

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?
READ MORE >

Shockwave Medical announces new studies evaluating carotid IVL platform

Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease. 

READ MORE >
the SKYWARD U.S. investigational device exemption (IDE) clinical program was launched to evaluate the Shockwave SkyRunner Carotid Intravascular Lithotripsy (IVL) System to break up carotid artery calcium prior to stenting.
Share on Twitter Share on Facebook Share on Linkedin

Shockwave Medical announces new studies evaluating carotid IVL platform

Share on Twitter Share on Facebook Share on Linkedin
the SKYWARD U.S. investigational device exemption (IDE) clinical program was launched to evaluate the Shockwave SkyRunner Carotid Intravascular Lithotripsy (IVL) System to break up carotid artery calcium prior to stenting.
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease. 
READ MORE >

In Other News

Jury awards family $18.2M after ‘never maneuver’ leaves child paralyzed for life

The incident happened in 2019 at a WakeMed hospital in Raleigh, North Carolina. Both the facility and the physician who performed the maneuver during the birth of Naqah Lake were found by a jury to be liable for the boy’s injuries. The verdict sets a record for the county.

READ MORE >
medical malpractice money
Share on Twitter Share on Facebook Share on Linkedin

Jury awards family $18.2M after ‘never maneuver’ leaves child paralyzed for life

Share on Twitter Share on Facebook Share on Linkedin
medical malpractice money
The incident happened in 2019 at a WakeMed hospital in Raleigh, North Carolina. Both the facility and the physician who performed the maneuver during the birth of Naqah Lake were found by a jury to be liable for the boy’s injuries. The verdict sets a record for the county.
READ MORE >

5 of 10 questions policy researchers—and all healthcare stakeholders—should be asking this year and next

In healthcare policymaking, priorities are like flaming swords to a circus juggler. It’s easy to take on one too many—and overlook the overreach until a burn or laceration halts the show. The word picture is suggested between the lines of a peer-reviewed paper published this month. 

READ MORE >
framework for regulating healthcare artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

5 of 10 questions policy researchers—and all healthcare stakeholders—should be asking this year and next

Share on Twitter Share on Facebook Share on Linkedin
framework for regulating healthcare artificial intelligence
In healthcare policymaking, priorities are like flaming swords to a circus juggler. It’s easy to take on one too many—and overlook the overreach until a burn or laceration halts the show. The word picture is suggested between the lines of a peer-reviewed paper published this month. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup